NCT06247163 PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
| NCT ID | NCT06247163 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Essen |
| Condition | Small Cell Lung Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-02-22 |
| Primary Completion | 2025-06-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-02-22 with a primary completion date of 2025-06-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
Eligibility Criteria
Inclusion Criteria: * Histopathologic confirmation * Limited disease Exclusion Criteria: * Other histology than small cell lung cancer * Further tumor diagnosis * ECOG 3 or worse * Extensive disease * stage IV
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06247163 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Small Cell Lung Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06247163 currently recruiting?
Yes, NCT06247163 is actively recruiting participants. Contact the research team at maja.guberina@uk-essen.de for enrollment information.
Where is the NCT06247163 trial being conducted?
This trial is being conducted at Essen, Germany.
Who is sponsoring the NCT06247163 clinical trial?
NCT06247163 is sponsored by University Hospital, Essen. The trial plans to enroll 30 participants.